Stem Cell treatment, Prochymal, for GvHD approved by FDA | 8 May 08, 16:15

Home | Support

Headline News:

Drug Testing

Stem Cell treatment, Prochymal, for GvHD approved by FDA

8 May 08, 16:15

COLUMBIA, Md. - Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced it has been given clearance by the US Food and Drug Administration (FDA) to initiate ...

more